Hudson Bay Capital Management LP Agios Pharmaceuticals, Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 60,000 shares of AGIO stock, worth $2.07 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
60,000
Previous 115,000
47.83%
Holding current value
$2.07 Million
Previous $4.96 Million
46.25%
% of portfolio
0.01%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$195 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$191 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$167 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$129 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$97.5 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.89B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...